nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—CYP2C9—Disulfiram—alcohol dependence	0.185	0.501	CbGbCtD
Meloxicam—CYP3A4—Disulfiram—alcohol dependence	0.108	0.291	CbGbCtD
Meloxicam—CYP3A4—Citalopram—alcohol dependence	0.0767	0.208	CbGbCtD
Meloxicam—PGD—forebrain—alcohol dependence	0.00295	0.042	CbGeAlD
Meloxicam—PGD—adrenal cortex—alcohol dependence	0.00273	0.0389	CbGeAlD
Meloxicam—PGD—cardiovascular system—alcohol dependence	0.00249	0.0355	CbGeAlD
Meloxicam—PGD—gonad—alcohol dependence	0.00226	0.0322	CbGeAlD
Meloxicam—ABCC4—forebrain—alcohol dependence	0.0021	0.0299	CbGeAlD
Meloxicam—PGD—digestive system—alcohol dependence	0.00207	0.0295	CbGeAlD
Meloxicam—PGD—blood—alcohol dependence	0.00197	0.0281	CbGeAlD
Meloxicam—PGD—midbrain—alcohol dependence	0.00195	0.0277	CbGeAlD
Meloxicam—ABCC4—pancreas—alcohol dependence	0.00172	0.0245	CbGeAlD
Meloxicam—PGD—endocrine gland—alcohol dependence	0.00171	0.0243	CbGeAlD
Meloxicam—PGD—testis—alcohol dependence	0.00163	0.0232	CbGeAlD
Meloxicam—PTGS1—Eicosanoid Synthesis—GGT1—alcohol dependence	0.00161	0.0118	CbGpPWpGaD
Meloxicam—PGD—nervous system—alcohol dependence	0.0016	0.0228	CbGeAlD
Meloxicam—PGD—liver—alcohol dependence	0.00154	0.022	CbGeAlD
Meloxicam—PGD—central nervous system—alcohol dependence	0.00154	0.0219	CbGeAlD
Meloxicam—PGD—cerebellum—alcohol dependence	0.00151	0.0214	CbGeAlD
Meloxicam—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.0015	0.011	CbGpPWpGaD
Meloxicam—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00149	0.011	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00149	0.011	CbGpPWpGaD
Meloxicam—ABCC4—digestive system—alcohol dependence	0.00147	0.021	CbGeAlD
Meloxicam—PGD—NRF2 pathway—SLC6A3—alcohol dependence	0.00144	0.0106	CbGpPWpGaD
Meloxicam—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00142	0.0105	CbGpPWpGaD
Meloxicam—ABCC4—blood—alcohol dependence	0.0014	0.02	CbGeAlD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00138	0.0102	CbGpPWpGaD
Meloxicam—PGD—NRF2 pathway—GGT1—alcohol dependence	0.00135	0.00995	CbGpPWpGaD
Meloxicam—CYP2C8—Xenobiotics—CYP2E1—alcohol dependence	0.00131	0.00964	CbGpPWpGaD
Meloxicam—PTGS2—Eicosanoid Synthesis—GGT1—alcohol dependence	0.00128	0.0094	CbGpPWpGaD
Meloxicam—CYP2C8—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00126	0.00927	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00123	0.00908	CbGpPWpGaD
Meloxicam—PTGS1—forebrain—alcohol dependence	0.00123	0.0176	CbGeAlD
Meloxicam—PTGS1—Biological oxidations—ADH6—alcohol dependence	0.00123	0.00902	CbGpPWpGaD
Meloxicam—PGD—brain—alcohol dependence	0.00122	0.0174	CbGeAlD
Meloxicam—ABCC4—endocrine gland—alcohol dependence	0.00122	0.0173	CbGeAlD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00121	0.00892	CbGpPWpGaD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00121	0.00892	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—GGT2—alcohol dependence	0.0012	0.00885	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—ADH7—alcohol dependence	0.00119	0.00874	CbGpPWpGaD
Meloxicam—PTGS2—forebrain—alcohol dependence	0.00118	0.0168	CbGeAlD
Meloxicam—ABCC4—testis—alcohol dependence	0.00116	0.0165	CbGeAlD
Meloxicam—CYP2C9—cardiovascular system—alcohol dependence	0.00114	0.0163	CbGeAlD
Meloxicam—ABCC4—NRF2 pathway—GGT2—alcohol dependence	0.00114	0.00838	CbGpPWpGaD
Meloxicam—ABCC4—nervous system—alcohol dependence	0.00114	0.0162	CbGeAlD
Meloxicam—ABCC4—liver—alcohol dependence	0.0011	0.0156	CbGeAlD
Meloxicam—ABCC4—central nervous system—alcohol dependence	0.0011	0.0156	CbGeAlD
Meloxicam—PTGS2—adrenal cortex—alcohol dependence	0.00109	0.0156	CbGeAlD
Meloxicam—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.00107	0.00784	CbGpPWpGaD
Meloxicam—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00105	0.00773	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00105	0.00772	CbGpPWpGaD
Meloxicam—PTGS1—cardiovascular system—alcohol dependence	0.00104	0.0149	CbGeAlD
Meloxicam—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00102	0.00754	CbGpPWpGaD
Meloxicam—CYP2C8—blood—alcohol dependence	0.00102	0.0145	CbGeAlD
Meloxicam—PTGS1—Biological oxidations—ADH1A—alcohol dependence	0.00102	0.00747	CbGpPWpGaD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.001	0.00739	CbGpPWpGaD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.001	0.00739	CbGpPWpGaD
Meloxicam—PTGS2—cardiovascular system—alcohol dependence	0.000997	0.0142	CbGeAlD
Meloxicam—PGD—Carbohydrate metabolism—GOT2—alcohol dependence	0.000991	0.00729	CbGpPWpGaD
Meloxicam—PTGS2—pancreas—alcohol dependence	0.000969	0.0138	CbGeAlD
Meloxicam—PTGS2—Selenium Micronutrient Network—GGT2—alcohol dependence	0.000955	0.00703	CbGpPWpGaD
Meloxicam—CYP2C9—digestive system—alcohol dependence	0.000949	0.0135	CbGeAlD
Meloxicam—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000929	0.00219	CcSEcCtD
Meloxicam—Pain in extremity—Citalopram—alcohol dependence	0.000929	0.00219	CcSEcCtD
Meloxicam—Angiopathy—Naltrexone—alcohol dependence	0.00092	0.00217	CcSEcCtD
Meloxicam—Flatulence—Acamprosate—alcohol dependence	0.00092	0.00217	CcSEcCtD
Meloxicam—Immune system disorder—Naltrexone—alcohol dependence	0.000916	0.00216	CcSEcCtD
Meloxicam—Tension—Acamprosate—alcohol dependence	0.000916	0.00216	CcSEcCtD
Meloxicam—Affect lability—Citalopram—alcohol dependence	0.000915	0.00215	CcSEcCtD
Meloxicam—Mediastinal disorder—Naltrexone—alcohol dependence	0.000914	0.00215	CcSEcCtD
Meloxicam—Dysgeusia—Acamprosate—alcohol dependence	0.000914	0.00215	CcSEcCtD
Meloxicam—Nervousness—Acamprosate—alcohol dependence	0.000907	0.00214	CcSEcCtD
Meloxicam—CYP2C9—blood—alcohol dependence	0.000904	0.0129	CbGeAlD
Meloxicam—Back pain—Acamprosate—alcohol dependence	0.000903	0.00213	CcSEcCtD
Meloxicam—Muscle spasms—Acamprosate—alcohol dependence	0.000897	0.00211	CcSEcCtD
Meloxicam—Face oedema—Citalopram—alcohol dependence	0.000897	0.00211	CcSEcCtD
Meloxicam—Alopecia—Naltrexone—alcohol dependence	0.000896	0.00211	CcSEcCtD
Meloxicam—PTGS1—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000894	0.00658	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000893	0.00657	CbGpPWpGaD
Meloxicam—Mental disorder—Naltrexone—alcohol dependence	0.000889	0.00209	CcSEcCtD
Meloxicam—Urinary retention—Citalopram—alcohol dependence	0.000884	0.00208	CcSEcCtD
Meloxicam—Malnutrition—Naltrexone—alcohol dependence	0.000883	0.00208	CcSEcCtD
Meloxicam—CYP2C8—endocrine gland—alcohol dependence	0.000882	0.0126	CbGeAlD
Meloxicam—Mood swings—Citalopram—alcohol dependence	0.00088	0.00207	CcSEcCtD
Meloxicam—Tremor—Acamprosate—alcohol dependence	0.000874	0.00206	CcSEcCtD
Meloxicam—Flatulence—Naltrexone—alcohol dependence	0.00087	0.00205	CcSEcCtD
Meloxicam—ABCC4—brain—alcohol dependence	0.000869	0.0124	CbGeAlD
Meloxicam—Tension—Naltrexone—alcohol dependence	0.000867	0.00204	CcSEcCtD
Meloxicam—Ill-defined disorder—Acamprosate—alcohol dependence	0.000866	0.00204	CcSEcCtD
Meloxicam—PTGS1—digestive system—alcohol dependence	0.000866	0.0123	CbGeAlD
Meloxicam—Dysgeusia—Naltrexone—alcohol dependence	0.000865	0.00204	CcSEcCtD
Meloxicam—Dehydration—Citalopram—alcohol dependence	0.000864	0.00204	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—ADH4—alcohol dependence	0.000863	0.00635	CbGpPWpGaD
Meloxicam—Anaemia—Acamprosate—alcohol dependence	0.000863	0.00203	CcSEcCtD
Meloxicam—Liver function test abnormal—Citalopram—alcohol dependence	0.000858	0.00202	CcSEcCtD
Meloxicam—Nervousness—Naltrexone—alcohol dependence	0.000858	0.00202	CcSEcCtD
Meloxicam—PGD—Carbohydrate metabolism—GOT1—alcohol dependence	0.000855	0.00629	CbGpPWpGaD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000854	0.00629	CbGpPWpGaD
Meloxicam—Back pain—Naltrexone—alcohol dependence	0.000854	0.00201	CcSEcCtD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000854	0.00628	CbGpPWpGaD
Meloxicam—Angioedema—Acamprosate—alcohol dependence	0.000853	0.00201	CcSEcCtD
Meloxicam—Muscle spasms—Naltrexone—alcohol dependence	0.000849	0.002	CcSEcCtD
Meloxicam—Abdominal pain upper—Citalopram—alcohol dependence	0.000849	0.002	CcSEcCtD
Meloxicam—Malaise—Acamprosate—alcohol dependence	0.000842	0.00198	CcSEcCtD
Meloxicam—CYP2C8—testis—alcohol dependence	0.000841	0.012	CbGeAlD
Meloxicam—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00084	0.00618	CbGpPWpGaD
Meloxicam—Vertigo—Acamprosate—alcohol dependence	0.000839	0.00198	CcSEcCtD
Meloxicam—Syncope—Acamprosate—alcohol dependence	0.000837	0.00197	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000837	0.00197	CcSEcCtD
Meloxicam—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000837	0.00197	CcSEcCtD
Meloxicam—Leukopenia—Acamprosate—alcohol dependence	0.000836	0.00197	CcSEcCtD
Meloxicam—Vision blurred—Naltrexone—alcohol dependence	0.000832	0.00196	CcSEcCtD
Meloxicam—Nasopharyngitis—Citalopram—alcohol dependence	0.000831	0.00196	CcSEcCtD
Meloxicam—PTGS2—digestive system—alcohol dependence	0.000828	0.0118	CbGeAlD
Meloxicam—Tremor—Naltrexone—alcohol dependence	0.000827	0.00195	CcSEcCtD
Meloxicam—PTGS1—blood—alcohol dependence	0.000825	0.0118	CbGeAlD
Meloxicam—Palpitations—Acamprosate—alcohol dependence	0.000825	0.00194	CcSEcCtD
Meloxicam—Gastritis—Citalopram—alcohol dependence	0.000822	0.00194	CcSEcCtD
Meloxicam—Loss of consciousness—Acamprosate—alcohol dependence	0.00082	0.00193	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000819	0.00193	CcSEcCtD
Meloxicam—Ill-defined disorder—Naltrexone—alcohol dependence	0.000819	0.00193	CcSEcCtD
Meloxicam—Cough—Acamprosate—alcohol dependence	0.000815	0.00192	CcSEcCtD
Meloxicam—Convulsion—Acamprosate—alcohol dependence	0.000809	0.00191	CcSEcCtD
Meloxicam—Angioedema—Naltrexone—alcohol dependence	0.000807	0.0019	CcSEcCtD
Meloxicam—Hypertension—Acamprosate—alcohol dependence	0.000806	0.0019	CcSEcCtD
Meloxicam—Asthma—Citalopram—alcohol dependence	0.000803	0.00189	CcSEcCtD
Meloxicam—Influenza—Citalopram—alcohol dependence	0.000803	0.00189	CcSEcCtD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.0008	0.00588	CbGpPWpGaD
Meloxicam—Malaise—Naltrexone—alcohol dependence	0.000796	0.00188	CcSEcCtD
Meloxicam—CYP2C8—liver—alcohol dependence	0.000796	0.0113	CbGeAlD
Meloxicam—Myalgia—Acamprosate—alcohol dependence	0.000795	0.00187	CcSEcCtD
Meloxicam—Arthralgia—Acamprosate—alcohol dependence	0.000795	0.00187	CcSEcCtD
Meloxicam—Syncope—Naltrexone—alcohol dependence	0.000792	0.00187	CcSEcCtD
Meloxicam—Anxiety—Acamprosate—alcohol dependence	0.000792	0.00187	CcSEcCtD
Meloxicam—CYP2C8—Biological oxidations—ADH6—alcohol dependence	0.000791	0.00582	CbGpPWpGaD
Meloxicam—Bronchospasm—Citalopram—alcohol dependence	0.00079	0.00186	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000789	0.00186	CcSEcCtD
Meloxicam—PTGS2—blood—alcohol dependence	0.000789	0.0112	CbGeAlD
Meloxicam—Pancreatitis—Citalopram—alcohol dependence	0.000787	0.00186	CcSEcCtD
Meloxicam—Discomfort—Acamprosate—alcohol dependence	0.000785	0.00185	CcSEcCtD
Meloxicam—CYP2C9—endocrine gland—alcohol dependence	0.000784	0.0112	CbGeAlD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000783	0.00576	CbGpPWpGaD
Meloxicam—Angina pectoris—Citalopram—alcohol dependence	0.000782	0.00184	CcSEcCtD
Meloxicam—Sweating increased—Citalopram—alcohol dependence	0.000782	0.00184	CcSEcCtD
Meloxicam—Palpitations—Naltrexone—alcohol dependence	0.00078	0.00184	CcSEcCtD
Meloxicam—PTGS2—midbrain—alcohol dependence	0.000779	0.0111	CbGeAlD
Meloxicam—Dry mouth—Acamprosate—alcohol dependence	0.000777	0.00183	CcSEcCtD
Meloxicam—Loss of consciousness—Naltrexone—alcohol dependence	0.000776	0.00183	CcSEcCtD
Meloxicam—Bronchitis—Citalopram—alcohol dependence	0.000772	0.00182	CcSEcCtD
Meloxicam—Cough—Naltrexone—alcohol dependence	0.000771	0.00182	CcSEcCtD
Meloxicam—Abdominal discomfort—Citalopram—alcohol dependence	0.00077	0.00181	CcSEcCtD
Meloxicam—Confusional state—Acamprosate—alcohol dependence	0.000768	0.00181	CcSEcCtD
Meloxicam—Convulsion—Naltrexone—alcohol dependence	0.000765	0.0018	CcSEcCtD
Meloxicam—Pancytopenia—Citalopram—alcohol dependence	0.000763	0.0018	CcSEcCtD
Meloxicam—Hypertension—Naltrexone—alcohol dependence	0.000762	0.0018	CcSEcCtD
Meloxicam—Anaphylactic shock—Acamprosate—alcohol dependence	0.000762	0.00179	CcSEcCtD
Meloxicam—Infection—Acamprosate—alcohol dependence	0.000757	0.00178	CcSEcCtD
Meloxicam—Arthralgia—Naltrexone—alcohol dependence	0.000752	0.00177	CcSEcCtD
Meloxicam—Myalgia—Naltrexone—alcohol dependence	0.000752	0.00177	CcSEcCtD
Meloxicam—Shock—Acamprosate—alcohol dependence	0.000749	0.00177	CcSEcCtD
Meloxicam—Anxiety—Naltrexone—alcohol dependence	0.000749	0.00177	CcSEcCtD
Meloxicam—PGD—Metabolism—ADH6—alcohol dependence	0.000747	0.0055	CbGpPWpGaD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000747	0.00176	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000746	0.00176	CcSEcCtD
Meloxicam—Thrombocytopenia—Acamprosate—alcohol dependence	0.000746	0.00176	CcSEcCtD
Meloxicam—Tachycardia—Acamprosate—alcohol dependence	0.000743	0.00175	CcSEcCtD
Meloxicam—Discomfort—Naltrexone—alcohol dependence	0.000743	0.00175	CcSEcCtD
Meloxicam—Pollakiuria—Citalopram—alcohol dependence	0.000742	0.00175	CcSEcCtD
Meloxicam—Skin disorder—Acamprosate—alcohol dependence	0.00074	0.00174	CcSEcCtD
Meloxicam—Hyperhidrosis—Acamprosate—alcohol dependence	0.000736	0.00174	CcSEcCtD
Meloxicam—Dry mouth—Naltrexone—alcohol dependence	0.000735	0.00173	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—ADH7—alcohol dependence	0.000734	0.0054	CbGpPWpGaD
Meloxicam—Photosensitivity reaction—Citalopram—alcohol dependence	0.000733	0.00173	CcSEcCtD
Meloxicam—Weight increased—Citalopram—alcohol dependence	0.000731	0.00172	CcSEcCtD
Meloxicam—Confusional state—Naltrexone—alcohol dependence	0.000727	0.00171	CcSEcCtD
Meloxicam—Weight decreased—Citalopram—alcohol dependence	0.000727	0.00171	CcSEcCtD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000726	0.00535	CbGpPWpGaD
Meloxicam—CYP3A4—digestive system—alcohol dependence	0.000723	0.0103	CbGeAlD
Meloxicam—Oedema—Naltrexone—alcohol dependence	0.000721	0.0017	CcSEcCtD
Meloxicam—Anaphylactic shock—Naltrexone—alcohol dependence	0.000721	0.0017	CcSEcCtD
Meloxicam—Infection—Naltrexone—alcohol dependence	0.000716	0.00169	CcSEcCtD
Meloxicam—Infestation NOS—Citalopram—alcohol dependence	0.000716	0.00169	CcSEcCtD
Meloxicam—Infestation—Citalopram—alcohol dependence	0.000716	0.00169	CcSEcCtD
Meloxicam—PTGS1—endocrine gland—alcohol dependence	0.000716	0.0102	CbGeAlD
Meloxicam—Hypotension—Acamprosate—alcohol dependence	0.000712	0.00168	CcSEcCtD
Meloxicam—PTGS2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00071	0.00522	CbGpPWpGaD
Meloxicam—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.00071	0.00167	CcSEcCtD
Meloxicam—Shock—Naltrexone—alcohol dependence	0.000709	0.00167	CcSEcCtD
Meloxicam—Nervous system disorder—Naltrexone—alcohol dependence	0.000707	0.00167	CcSEcCtD
Meloxicam—CYP2C9—liver—alcohol dependence	0.000707	0.0101	CbGeAlD
Meloxicam—Acute coronary syndrome—Citalopram—alcohol dependence	0.000706	0.00166	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—GGT2—alcohol dependence	0.000704	0.00518	CbGpPWpGaD
Meloxicam—Tachycardia—Naltrexone—alcohol dependence	0.000703	0.00166	CcSEcCtD
Meloxicam—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000703	0.00517	CbGpPWpGaD
Meloxicam—Myocardial infarction—Citalopram—alcohol dependence	0.000702	0.00165	CcSEcCtD
Meloxicam—Skin disorder—Naltrexone—alcohol dependence	0.0007	0.00165	CcSEcCtD
Meloxicam—Stomatitis—Citalopram—alcohol dependence	0.000698	0.00164	CcSEcCtD
Meloxicam—Jaundice—Citalopram—alcohol dependence	0.000698	0.00164	CcSEcCtD
Meloxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000697	0.00513	CbGpPWpGaD
Meloxicam—Hyperhidrosis—Naltrexone—alcohol dependence	0.000697	0.00164	CcSEcCtD
Meloxicam—Conjunctivitis—Citalopram—alcohol dependence	0.000696	0.00164	CcSEcCtD
Meloxicam—Urinary tract infection—Citalopram—alcohol dependence	0.000696	0.00164	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000694	0.00164	CcSEcCtD
Meloxicam—CYP3A4—blood—alcohol dependence	0.000689	0.00982	CbGeAlD
Meloxicam—Insomnia—Acamprosate—alcohol dependence	0.000689	0.00162	CcSEcCtD
Meloxicam—Sweating—Citalopram—alcohol dependence	0.000686	0.00162	CcSEcCtD
Meloxicam—Paraesthesia—Acamprosate—alcohol dependence	0.000684	0.00161	CcSEcCtD
Meloxicam—PTGS2—endocrine gland—alcohol dependence	0.000684	0.00974	CbGeAlD
Meloxicam—Haematuria—Citalopram—alcohol dependence	0.000683	0.00161	CcSEcCtD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000682	0.00502	CbGpPWpGaD
Meloxicam—PTGS1—testis—alcohol dependence	0.000682	0.00972	CbGeAlD
Meloxicam—Dyspnoea—Acamprosate—alcohol dependence	0.000679	0.0016	CcSEcCtD
Meloxicam—Somnolence—Acamprosate—alcohol dependence	0.000677	0.0016	CcSEcCtD
Meloxicam—Hepatobiliary disease—Citalopram—alcohol dependence	0.000677	0.0016	CcSEcCtD
Meloxicam—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000676	0.00497	CbGpPWpGaD
Meloxicam—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000672	0.00495	CbGpPWpGaD
Meloxicam—Sinusitis—Citalopram—alcohol dependence	0.000672	0.00158	CcSEcCtD
Meloxicam—Dyspepsia—Acamprosate—alcohol dependence	0.000671	0.00158	CcSEcCtD
Meloxicam—PTGS1—nervous system—alcohol dependence	0.00067	0.00954	CbGeAlD
Meloxicam—Agranulocytosis—Citalopram—alcohol dependence	0.000668	0.00157	CcSEcCtD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000663	0.00488	CbGpPWpGaD
Meloxicam—Decreased appetite—Acamprosate—alcohol dependence	0.000662	0.00156	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000658	0.00155	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000657	0.00155	CcSEcCtD
Meloxicam—CYP2C8—Biological oxidations—ADH1A—alcohol dependence	0.000656	0.00483	CbGpPWpGaD
Meloxicam—Insomnia—Naltrexone—alcohol dependence	0.000652	0.00154	CcSEcCtD
Meloxicam—Constipation—Acamprosate—alcohol dependence	0.000651	0.00153	CcSEcCtD
Meloxicam—Pain—Acamprosate—alcohol dependence	0.000651	0.00153	CcSEcCtD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000648	0.00477	CbGpPWpGaD
Meloxicam—Paraesthesia—Naltrexone—alcohol dependence	0.000647	0.00152	CcSEcCtD
Meloxicam—Haemoglobin—Citalopram—alcohol dependence	0.000646	0.00152	CcSEcCtD
Meloxicam—PTGS1—central nervous system—alcohol dependence	0.000645	0.00919	CbGeAlD
Meloxicam—Rhinitis—Citalopram—alcohol dependence	0.000644	0.00152	CcSEcCtD
Meloxicam—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000644	0.00474	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—ADH1B—alcohol dependence	0.000644	0.00474	CbGpPWpGaD
Meloxicam—Hepatitis—Citalopram—alcohol dependence	0.000643	0.00151	CcSEcCtD
Meloxicam—Haemorrhage—Citalopram—alcohol dependence	0.000643	0.00151	CcSEcCtD
Meloxicam—Dyspnoea—Naltrexone—alcohol dependence	0.000643	0.00151	CcSEcCtD
Meloxicam—PTGS2—Spinal Cord Injury—PDYN—alcohol dependence	0.000642	0.00472	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—SLC6A4—alcohol dependence	0.000641	0.00472	CbGpPWpGaD
Meloxicam—Somnolence—Naltrexone—alcohol dependence	0.000641	0.00151	CcSEcCtD
Meloxicam—PTGS2—nervous system—alcohol dependence	0.00064	0.00912	CbGeAlD
Meloxicam—Pharyngitis—Citalopram—alcohol dependence	0.000638	0.0015	CcSEcCtD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000637	0.00469	CbGpPWpGaD
Meloxicam—Urinary tract disorder—Citalopram—alcohol dependence	0.000635	0.0015	CcSEcCtD
Meloxicam—Oedema peripheral—Citalopram—alcohol dependence	0.000633	0.00149	CcSEcCtD
Meloxicam—Connective tissue disorder—Citalopram—alcohol dependence	0.000632	0.00149	CcSEcCtD
Meloxicam—CYP2C8—brain—alcohol dependence	0.000631	0.00899	CbGeAlD
Meloxicam—Urethral disorder—Citalopram—alcohol dependence	0.00063	0.00148	CcSEcCtD
Meloxicam—Feeling abnormal—Acamprosate—alcohol dependence	0.000628	0.00148	CcSEcCtD
Meloxicam—Decreased appetite—Naltrexone—alcohol dependence	0.000627	0.00148	CcSEcCtD
Meloxicam—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000623	0.00147	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000622	0.00147	CcSEcCtD
Meloxicam—Fatigue—Naltrexone—alcohol dependence	0.000621	0.00146	CcSEcCtD
Meloxicam—Visual impairment—Citalopram—alcohol dependence	0.000619	0.00146	CcSEcCtD
Meloxicam—PGD—Metabolism—ADH1A—alcohol dependence	0.000619	0.00455	CbGpPWpGaD
Meloxicam—PTGS2—liver—alcohol dependence	0.000617	0.00879	CbGeAlD
Meloxicam—Pain—Naltrexone—alcohol dependence	0.000616	0.00145	CcSEcCtD
Meloxicam—Constipation—Naltrexone—alcohol dependence	0.000616	0.00145	CcSEcCtD
Meloxicam—PTGS2—central nervous system—alcohol dependence	0.000616	0.00878	CbGeAlD
Meloxicam—Erythema multiforme—Citalopram—alcohol dependence	0.000608	0.00143	CcSEcCtD
Meloxicam—Urticaria—Acamprosate—alcohol dependence	0.000605	0.00143	CcSEcCtD
Meloxicam—PTGS2—cerebellum—alcohol dependence	0.000602	0.00858	CbGeAlD
Meloxicam—Body temperature increased—Acamprosate—alcohol dependence	0.000602	0.00142	CcSEcCtD
Meloxicam—Abdominal pain—Acamprosate—alcohol dependence	0.000602	0.00142	CcSEcCtD
Meloxicam—Eye disorder—Citalopram—alcohol dependence	0.000601	0.00142	CcSEcCtD
Meloxicam—Tinnitus—Citalopram—alcohol dependence	0.000599	0.00141	CcSEcCtD
Meloxicam—CYP3A4—endocrine gland—alcohol dependence	0.000598	0.00852	CbGeAlD
Meloxicam—Flushing—Citalopram—alcohol dependence	0.000597	0.00141	CcSEcCtD
Meloxicam—Cardiac disorder—Citalopram—alcohol dependence	0.000597	0.00141	CcSEcCtD
Meloxicam—Feeling abnormal—Naltrexone—alcohol dependence	0.000594	0.0014	CcSEcCtD
Meloxicam—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000589	0.00139	CcSEcCtD
Meloxicam—Angiopathy—Citalopram—alcohol dependence	0.000583	0.00137	CcSEcCtD
Meloxicam—Immune system disorder—Citalopram—alcohol dependence	0.000581	0.00137	CcSEcCtD
Meloxicam—Mediastinal disorder—Citalopram—alcohol dependence	0.000579	0.00136	CcSEcCtD
Meloxicam—CYP2C8—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000578	0.00425	CbGpPWpGaD
Meloxicam—Arrhythmia—Citalopram—alcohol dependence	0.000574	0.00135	CcSEcCtD
Meloxicam—Urticaria—Naltrexone—alcohol dependence	0.000573	0.00135	CcSEcCtD
Meloxicam—ABCC4—NRF2 pathway—SLC6A3—alcohol dependence	0.000572	0.00421	CbGpPWpGaD
Meloxicam—Abdominal pain—Naltrexone—alcohol dependence	0.00057	0.00134	CcSEcCtD
Meloxicam—Body temperature increased—Naltrexone—alcohol dependence	0.00057	0.00134	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000569	0.00419	CbGpPWpGaD
Meloxicam—Alopecia—Citalopram—alcohol dependence	0.000568	0.00134	CcSEcCtD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000563	0.00415	CbGpPWpGaD
Meloxicam—Mental disorder—Citalopram—alcohol dependence	0.000563	0.00133	CcSEcCtD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000561	0.00413	CbGpPWpGaD
Meloxicam—Hypersensitivity—Acamprosate—alcohol dependence	0.000561	0.00132	CcSEcCtD
Meloxicam—Erythema—Citalopram—alcohol dependence	0.00056	0.00132	CcSEcCtD
Meloxicam—Malnutrition—Citalopram—alcohol dependence	0.00056	0.00132	CcSEcCtD
Meloxicam—CYP3A4—nervous system—alcohol dependence	0.000559	0.00797	CbGeAlD
Meloxicam—CYP2C8—Biological oxidations—ADH4—alcohol dependence	0.000558	0.0041	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000551	0.00406	CbGpPWpGaD
Meloxicam—Flatulence—Citalopram—alcohol dependence	0.000551	0.0013	CcSEcCtD
Meloxicam—Tension—Citalopram—alcohol dependence	0.000549	0.00129	CcSEcCtD
Meloxicam—Dysgeusia—Citalopram—alcohol dependence	0.000548	0.00129	CcSEcCtD
Meloxicam—Asthenia—Acamprosate—alcohol dependence	0.000547	0.00129	CcSEcCtD
Meloxicam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000544	0.004	CbGpPWpGaD
Meloxicam—Nervousness—Citalopram—alcohol dependence	0.000543	0.00128	CcSEcCtD
Meloxicam—Back pain—Citalopram—alcohol dependence	0.000541	0.00128	CcSEcCtD
Meloxicam—Pruritus—Acamprosate—alcohol dependence	0.000539	0.00127	CcSEcCtD
Meloxicam—CYP3A4—liver—alcohol dependence	0.000539	0.00768	CbGeAlD
Meloxicam—CYP3A4—central nervous system—alcohol dependence	0.000539	0.00767	CbGeAlD
Meloxicam—ABCC4—NRF2 pathway—GGT1—alcohol dependence	0.000539	0.00396	CbGpPWpGaD
Meloxicam—Muscle spasms—Citalopram—alcohol dependence	0.000538	0.00127	CcSEcCtD
Meloxicam—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000537	0.00395	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000534	0.00393	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—MAOB—alcohol dependence	0.000533	0.00392	CbGpPWpGaD
Meloxicam—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000531	0.00391	CbGpPWpGaD
Meloxicam—Hypersensitivity—Naltrexone—alcohol dependence	0.000531	0.00125	CcSEcCtD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000528	0.00388	CbGpPWpGaD
Meloxicam—Vision blurred—Citalopram—alcohol dependence	0.000527	0.00124	CcSEcCtD
Meloxicam—PGD—Metabolism—ADH4—alcohol dependence	0.000526	0.00387	CbGpPWpGaD
Meloxicam—Tremor—Citalopram—alcohol dependence	0.000524	0.00124	CcSEcCtD
Meloxicam—Diarrhoea—Acamprosate—alcohol dependence	0.000521	0.00123	CcSEcCtD
Meloxicam—Ill-defined disorder—Citalopram—alcohol dependence	0.000519	0.00122	CcSEcCtD
Meloxicam—Anaemia—Citalopram—alcohol dependence	0.000517	0.00122	CcSEcCtD
Meloxicam—Asthenia—Naltrexone—alcohol dependence	0.000517	0.00122	CcSEcCtD
Meloxicam—PTGS1—brain—alcohol dependence	0.000512	0.00729	CbGeAlD
Meloxicam—Angioedema—Citalopram—alcohol dependence	0.000511	0.0012	CcSEcCtD
Meloxicam—Pruritus—Naltrexone—alcohol dependence	0.00051	0.0012	CcSEcCtD
Meloxicam—Malaise—Citalopram—alcohol dependence	0.000505	0.00119	CcSEcCtD
Meloxicam—Dizziness—Acamprosate—alcohol dependence	0.000504	0.00119	CcSEcCtD
Meloxicam—Vertigo—Citalopram—alcohol dependence	0.000503	0.00118	CcSEcCtD
Meloxicam—Syncope—Citalopram—alcohol dependence	0.000502	0.00118	CcSEcCtD
Meloxicam—Leukopenia—Citalopram—alcohol dependence	0.000501	0.00118	CcSEcCtD
Meloxicam—Palpitations—Citalopram—alcohol dependence	0.000494	0.00117	CcSEcCtD
Meloxicam—Diarrhoea—Naltrexone—alcohol dependence	0.000493	0.00116	CcSEcCtD
Meloxicam—Loss of consciousness—Citalopram—alcohol dependence	0.000492	0.00116	CcSEcCtD
Meloxicam—PTGS2—brain—alcohol dependence	0.000489	0.00697	CbGeAlD
Meloxicam—Cough—Citalopram—alcohol dependence	0.000488	0.00115	CcSEcCtD
Meloxicam—Convulsion—Citalopram—alcohol dependence	0.000485	0.00114	CcSEcCtD
Meloxicam—Vomiting—Acamprosate—alcohol dependence	0.000484	0.00114	CcSEcCtD
Meloxicam—Hypertension—Citalopram—alcohol dependence	0.000483	0.00114	CcSEcCtD
Meloxicam—Rash—Acamprosate—alcohol dependence	0.00048	0.00113	CcSEcCtD
Meloxicam—Dermatitis—Acamprosate—alcohol dependence	0.00048	0.00113	CcSEcCtD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000479	0.00353	CbGpPWpGaD
Meloxicam—Headache—Acamprosate—alcohol dependence	0.000477	0.00112	CcSEcCtD
Meloxicam—Dizziness—Naltrexone—alcohol dependence	0.000477	0.00112	CcSEcCtD
Meloxicam—Arthralgia—Citalopram—alcohol dependence	0.000476	0.00112	CcSEcCtD
Meloxicam—Myalgia—Citalopram—alcohol dependence	0.000476	0.00112	CcSEcCtD
Meloxicam—Anxiety—Citalopram—alcohol dependence	0.000475	0.00112	CcSEcCtD
Meloxicam—CYP2C8—Biological oxidations—ADH7—alcohol dependence	0.000474	0.00349	CbGpPWpGaD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000473	0.00111	CcSEcCtD
Meloxicam—Discomfort—Citalopram—alcohol dependence	0.000471	0.00111	CcSEcCtD
Meloxicam—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00047	0.00346	CbGpPWpGaD
Meloxicam—Dry mouth—Citalopram—alcohol dependence	0.000466	0.0011	CcSEcCtD
Meloxicam—Confusional state—Citalopram—alcohol dependence	0.00046	0.00108	CcSEcCtD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00046	0.00338	CbGpPWpGaD
Meloxicam—Vomiting—Naltrexone—alcohol dependence	0.000458	0.00108	CcSEcCtD
Meloxicam—Anaphylactic shock—Citalopram—alcohol dependence	0.000457	0.00108	CcSEcCtD
Meloxicam—Oedema—Citalopram—alcohol dependence	0.000457	0.00108	CcSEcCtD
Meloxicam—CYP2C8—Biological oxidations—GGT2—alcohol dependence	0.000455	0.00334	CbGpPWpGaD
Meloxicam—Rash—Naltrexone—alcohol dependence	0.000454	0.00107	CcSEcCtD
Meloxicam—Dermatitis—Naltrexone—alcohol dependence	0.000454	0.00107	CcSEcCtD
Meloxicam—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000454	0.00334	CbGpPWpGaD
Meloxicam—Infection—Citalopram—alcohol dependence	0.000454	0.00107	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—ALDH2—alcohol dependence	0.000453	0.00334	CbGpPWpGaD
Meloxicam—Nausea—Acamprosate—alcohol dependence	0.000452	0.00107	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000452	0.00332	CbGpPWpGaD
Meloxicam—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000452	0.00332	CbGpPWpGaD
Meloxicam—Headache—Naltrexone—alcohol dependence	0.000452	0.00106	CcSEcCtD
Meloxicam—Shock—Citalopram—alcohol dependence	0.000449	0.00106	CcSEcCtD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000449	0.0033	CbGpPWpGaD
Meloxicam—Nervous system disorder—Citalopram—alcohol dependence	0.000448	0.00106	CcSEcCtD
Meloxicam—PGD—Metabolism—ADH7—alcohol dependence	0.000448	0.00329	CbGpPWpGaD
Meloxicam—Thrombocytopenia—Citalopram—alcohol dependence	0.000447	0.00105	CcSEcCtD
Meloxicam—Tachycardia—Citalopram—alcohol dependence	0.000446	0.00105	CcSEcCtD
Meloxicam—Skin disorder—Citalopram—alcohol dependence	0.000444	0.00105	CcSEcCtD
Meloxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000443	0.00326	CbGpPWpGaD
Meloxicam—Hyperhidrosis—Citalopram—alcohol dependence	0.000441	0.00104	CcSEcCtD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000441	0.00324	CbGpPWpGaD
Meloxicam—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000437	0.00321	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GGT2—alcohol dependence	0.000429	0.00316	CbGpPWpGaD
Meloxicam—Nausea—Naltrexone—alcohol dependence	0.000428	0.00101	CcSEcCtD
Meloxicam—Hypotension—Citalopram—alcohol dependence	0.000427	0.00101	CcSEcCtD
Meloxicam—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000425	0.00313	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00042	0.00309	CbGpPWpGaD
Meloxicam—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000416	0.00098	CcSEcCtD
Meloxicam—CYP2C8—Biological oxidations—ADH1B—alcohol dependence	0.000416	0.00306	CbGpPWpGaD
Meloxicam—Insomnia—Citalopram—alcohol dependence	0.000413	0.000973	CcSEcCtD
Meloxicam—Paraesthesia—Citalopram—alcohol dependence	0.00041	0.000966	CcSEcCtD
Meloxicam—Dyspnoea—Citalopram—alcohol dependence	0.000407	0.000959	CcSEcCtD
Meloxicam—Somnolence—Citalopram—alcohol dependence	0.000406	0.000957	CcSEcCtD
Meloxicam—Dyspepsia—Citalopram—alcohol dependence	0.000402	0.000947	CcSEcCtD
Meloxicam—Decreased appetite—Citalopram—alcohol dependence	0.000397	0.000935	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000394	0.000929	CcSEcCtD
Meloxicam—Fatigue—Citalopram—alcohol dependence	0.000394	0.000928	CcSEcCtD
Meloxicam—PGD—Metabolism—ADH1B—alcohol dependence	0.000392	0.00289	CbGpPWpGaD
Meloxicam—Pain—Citalopram—alcohol dependence	0.000391	0.00092	CcSEcCtD
Meloxicam—Constipation—Citalopram—alcohol dependence	0.000391	0.00092	CcSEcCtD
Meloxicam—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000386	0.00284	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.00038	0.0028	CbGpPWpGaD
Meloxicam—Feeling abnormal—Citalopram—alcohol dependence	0.000376	0.000887	CcSEcCtD
Meloxicam—Gastrointestinal pain—Citalopram—alcohol dependence	0.000373	0.00088	CcSEcCtD
Meloxicam—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.00037	0.00272	CbGpPWpGaD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000366	0.00269	CbGpPWpGaD
Meloxicam—Urticaria—Citalopram—alcohol dependence	0.000363	0.000855	CcSEcCtD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000363	0.00267	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—CYP2E1—alcohol dependence	0.000363	0.00267	CbGpPWpGaD
Meloxicam—Abdominal pain—Citalopram—alcohol dependence	0.000361	0.000851	CcSEcCtD
Meloxicam—Body temperature increased—Citalopram—alcohol dependence	0.000361	0.000851	CcSEcCtD
Meloxicam—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000361	0.00266	CbGpPWpGaD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000359	0.00264	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000352	0.00259	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000348	0.00256	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—MAOB—alcohol dependence	0.000344	0.00253	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000338	0.00249	CbGpPWpGaD
Meloxicam—Hypersensitivity—Citalopram—alcohol dependence	0.000336	0.000793	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—GGT1—alcohol dependence	0.000333	0.00245	CbGpPWpGaD
Meloxicam—Asthenia—Citalopram—alcohol dependence	0.000328	0.000772	CcSEcCtD
Meloxicam—PGD—Metabolism—MAOB—alcohol dependence	0.000325	0.00239	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000323	0.00238	CbGpPWpGaD
Meloxicam—Pruritus—Citalopram—alcohol dependence	0.000323	0.000761	CcSEcCtD
Meloxicam—Diarrhoea—Citalopram—alcohol dependence	0.000312	0.000736	CcSEcCtD
Meloxicam—Dizziness—Citalopram—alcohol dependence	0.000302	0.000712	CcSEcCtD
Meloxicam—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000299	0.0022	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—MAOA—alcohol dependence	0.000298	0.00219	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000296	0.00218	CbGpPWpGaD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000295	0.00217	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000294	0.00216	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—ALDH2—alcohol dependence	0.000293	0.00216	CbGpPWpGaD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000292	0.00215	CbGpPWpGaD
Meloxicam—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000291	0.00214	CbGpPWpGaD
Meloxicam—Vomiting—Citalopram—alcohol dependence	0.00029	0.000684	CcSEcCtD
Meloxicam—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000288	0.00212	CbGpPWpGaD
Meloxicam—Rash—Citalopram—alcohol dependence	0.000288	0.000678	CcSEcCtD
Meloxicam—Dermatitis—Citalopram—alcohol dependence	0.000288	0.000678	CcSEcCtD
Meloxicam—Headache—Citalopram—alcohol dependence	0.000286	0.000674	CcSEcCtD
Meloxicam—PGD—Disease—GOT2—alcohol dependence	0.000281	0.00207	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.00028	0.00206	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ALDH2—alcohol dependence	0.000276	0.00203	CbGpPWpGaD
Meloxicam—Nausea—Citalopram—alcohol dependence	0.000271	0.000639	CcSEcCtD
Meloxicam—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000254	0.00187	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000244	0.0018	CbGpPWpGaD
Meloxicam—PGD—Disease—GOT1—alcohol dependence	0.000242	0.00178	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000238	0.00175	CbGpPWpGaD
Meloxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000237	0.00174	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000237	0.00174	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000236	0.00174	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GOT2—alcohol dependence	0.000235	0.00173	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—CYP2E1—alcohol dependence	0.000234	0.00172	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000231	0.0017	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000223	0.00164	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CYP2E1—alcohol dependence	0.000221	0.00163	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—GGT1—alcohol dependence	0.000215	0.00158	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ADH6—alcohol dependence	0.00021	0.00154	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GOT1—alcohol dependence	0.000203	0.00149	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GGT1—alcohol dependence	0.000203	0.00149	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000195	0.00143	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—POMC—alcohol dependence	0.000194	0.00143	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—MAOA—alcohol dependence	0.000193	0.00142	CbGpPWpGaD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000192	0.00141	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000191	0.0014	CbGpPWpGaD
Meloxicam—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000188	0.00138	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000185	0.00136	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000183	0.00135	CbGpPWpGaD
Meloxicam—PGD—Metabolism—MAOA—alcohol dependence	0.000182	0.00134	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—EP300—alcohol dependence	0.000181	0.00134	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000175	0.00129	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ADH1A—alcohol dependence	0.000174	0.00128	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADH6—alcohol dependence	0.000166	0.00122	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000157	0.00116	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000157	0.00115	CbGpPWpGaD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000156	0.00115	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000151	0.00111	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ADH4—alcohol dependence	0.000148	0.00109	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADH1A—alcohol dependence	0.000138	0.00101	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADH6—alcohol dependence	0.000135	0.000996	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000128	0.00094	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000127	0.000933	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000126	0.000925	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ADH7—alcohol dependence	0.000126	0.000924	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—POMC—alcohol dependence	0.000125	0.000923	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000124	0.000912	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GGT2—alcohol dependence	0.00012	0.000886	CbGpPWpGaD
Meloxicam—PGD—Metabolism—POMC—alcohol dependence	0.000118	0.000871	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADH4—alcohol dependence	0.000117	0.000862	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000115	0.000849	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADH1A—alcohol dependence	0.000112	0.000825	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADH6—alcohol dependence	0.00011	0.000811	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ADH1B—alcohol dependence	0.00011	0.00081	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000103	0.000761	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—POMC—alcohol dependence	0.000102	0.000751	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000101	0.000747	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADH7—alcohol dependence	9.96e-05	0.000733	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GGT2—alcohol dependence	9.55e-05	0.000703	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADH4—alcohol dependence	9.54e-05	0.000702	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	9.4e-05	0.000692	CbGpPWpGaD
Meloxicam—PGD—Disease—EP300—alcohol dependence	9.38e-05	0.00069	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADH1A—alcohol dependence	9.13e-05	0.000672	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—MAOB—alcohol dependence	9.12e-05	0.000671	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADH1B—alcohol dependence	8.74e-05	0.000643	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	8.26e-05	0.000607	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADH7—alcohol dependence	8.11e-05	0.000597	CbGpPWpGaD
Meloxicam—PGD—Metabolism—EP300—alcohol dependence	7.85e-05	0.000578	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GGT2—alcohol dependence	7.77e-05	0.000572	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADH4—alcohol dependence	7.76e-05	0.000571	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALDH2—alcohol dependence	7.75e-05	0.000571	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—EP300—alcohol dependence	7.71e-05	0.000567	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	7.46e-05	0.000549	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADH6—alcohol dependence	7.26e-05	0.000535	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—MAOB—alcohol dependence	7.24e-05	0.000533	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADH1B—alcohol dependence	7.11e-05	0.000523	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—POMC—alcohol dependence	6.73e-05	0.000495	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.72e-05	0.000494	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADH7—alcohol dependence	6.6e-05	0.000486	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GOT2—alcohol dependence	6.59e-05	0.000485	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GGT2—alcohol dependence	6.33e-05	0.000466	CbGpPWpGaD
Meloxicam—PTGS2—Disease—GOT2—alcohol dependence	6.25e-05	0.00046	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP2E1—alcohol dependence	6.2e-05	0.000456	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALDH2—alcohol dependence	6.16e-05	0.000453	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADH1A—alcohol dependence	6.02e-05	0.000443	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	5.92e-05	0.000436	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—MAOB—alcohol dependence	5.89e-05	0.000433	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADH1B—alcohol dependence	5.79e-05	0.000426	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GOT1—alcohol dependence	5.69e-05	0.000419	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GGT1—alcohol dependence	5.69e-05	0.000419	CbGpPWpGaD
Meloxicam—PTGS2—Disease—GOT1—alcohol dependence	5.4e-05	0.000397	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GOT2—alcohol dependence	5.23e-05	0.000385	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADH4—alcohol dependence	5.12e-05	0.000377	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—MAOA—alcohol dependence	5.1e-05	0.000375	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALDH2—alcohol dependence	5.01e-05	0.000369	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.95e-05	0.000364	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP2E1—alcohol dependence	4.92e-05	0.000362	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.82e-05	0.000354	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MAOB—alcohol dependence	4.79e-05	0.000353	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GGT1—alcohol dependence	4.52e-05	0.000332	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GOT1—alcohol dependence	4.52e-05	0.000332	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADH7—alcohol dependence	4.35e-05	0.00032	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GOT2—alcohol dependence	4.26e-05	0.000313	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GGT2—alcohol dependence	4.17e-05	0.000307	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALDH2—alcohol dependence	4.08e-05	0.0003	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—MAOA—alcohol dependence	4.05e-05	0.000298	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP2E1—alcohol dependence	4e-05	0.000295	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.93e-05	0.000289	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.92e-05	0.000288	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.82e-05	0.000281	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GGT1—alcohol dependence	3.68e-05	0.000271	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GOT1—alcohol dependence	3.68e-05	0.000271	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GOT2—alcohol dependence	3.47e-05	0.000255	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—POMC—alcohol dependence	3.32e-05	0.000244	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—MAOA—alcohol dependence	3.29e-05	0.000242	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP2E1—alcohol dependence	3.26e-05	0.00024	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.2e-05	0.000235	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MAOB—alcohol dependence	3.16e-05	0.000233	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GOT1—alcohol dependence	2.99e-05	0.00022	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GGT1—alcohol dependence	2.99e-05	0.00022	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.69e-05	0.000198	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MAOA—alcohol dependence	2.68e-05	0.000197	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—POMC—alcohol dependence	2.64e-05	0.000194	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.6e-05	0.000191	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GOT2—alcohol dependence	2.29e-05	0.000168	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—EP300—alcohol dependence	2.2e-05	0.000162	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.15e-05	0.000158	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—POMC—alcohol dependence	2.14e-05	0.000158	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EP300—alcohol dependence	2.09e-05	0.000154	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GGT1—alcohol dependence	1.97e-05	0.000145	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GOT1—alcohol dependence	1.97e-05	0.000145	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MAOA—alcohol dependence	1.77e-05	0.00013	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—EP300—alcohol dependence	1.75e-05	0.000129	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—POMC—alcohol dependence	1.75e-05	0.000128	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—EP300—alcohol dependence	1.42e-05	0.000105	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—EP300—alcohol dependence	1.16e-05	8.52e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—POMC—alcohol dependence	1.15e-05	8.47e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—EP300—alcohol dependence	7.64e-06	5.62e-05	CbGpPWpGaD
